Full Text
PND15- COST-EFFECTIVENESS OF THERAPY FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS)- INTRODUCING AN ECONOMIC MODEL FOR COPAXONE (GLATIRAMER ACETATE)

Abstract

Authors

UK Bose

Back to Volume 4, Issue 6
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×